<DOC>
<DOCNO>1061228_business_story_7192898.utf8</DOCNO>
<TEXT>


The Telegraph - Calcutta : Business

 Cornerstone, Lupin cut link

 Mumbai, Dec. 27 (PTI): Pharma companies Lupin and Cornerstone Biopharma will end a development agreement, signed in May 2005, for an anti-infective in the US market.

 Both parties have mutually agreed to end the development agreement, Lupin informed the Bombay Stock Exchange.

 Lupin plans to continue with the product development and would look for a partner to market in the US, it said. 




</TEXT>
</DOC>